We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · January 06, 2020

Effect of rFVIIa on Hemorrhage Expansion Among Patients With Spot Sign–Positive Acute Intracerebral Hemorrhage

JAMA Neurology


Additional Info

JAMA Neurology
Effect of Recombinant Activated Coagulation Factor VII on Hemorrhage Expansion Among Patients With Spot Sign-Positive Acute Intracerebral Hemorrhage: The SPOTLIGHT and STOP-IT Randomized Clinical Trials
JAMA Neurol 2019 Dec 01;76(12)1493-1501, DJ Gladstone, RI Aviv, AM Demchuk, MD Hill, KE Thorpe, JC Khoury, HJ Sucharew, F Al-Ajlan, K Butcher, D Dowlatshahi, G Gubitz, S De Masi, J Hall, D Gregg, M Mamdani, M Shamy, RH Swartz, CM Del Campo, B Cucchiara, P Panagos, JN Goldstein, J Carrozzella, EC Jauch, JP Broderick, ML Flaherty

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading